SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-021058
Filing Date
2024-08-09
Accepted
2024-08-09 19:06:03
Documents
2
Period of Report
2024-08-08

Document Format Files

Seq Description Document Type Size
1 form3-08092024_110859.html 3  
1 form3-08092024_110859.xml 3 8475
2 ex24-08092024_110801.htm EX-24 4761
  Complete submission text file 0001415889-24-021058.txt   14733
Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Issuer) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O JANUX THERAPEUTICS, INC. 10955 VISTA SORRENTO PARKWAY, SUITE 200 SAN DIEGO CA 92130
Business Address
Dobek Maria (Reporting) CIK: 0002032671 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40475 | Film No.: 241194336